Drug Search Results

Resatorvid

Alternative Names: resatorvid, tak-242, tak 242, tak242
Latest Update: 2024-06-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TLR4 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Resatorvid

Countries in Clinic: Germany, Portugal, Spain

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Acute Kidney Injury|Kidney Diseases|Liver Cirrhosis|Liver Failure, Acute|Respiratory Insufficiency

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
G-TAK-ES-01	P2	Unknown Status	Acute Kidney Injury\|Liver Failure, Acute\|Kidney Diseases\|Respiratory Insufficiency\|Liver Cirrhosis	2025-01-31

Recent News Events

Date	Type	Title
05/11/2024	PubMed	TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.
05/07/2024	PubMed	Sinomenine attenuates bleomycin-induced pulmonary fibrosis, inflammation, and oxidative stress by inhibiting TLR4/NLRP3/TGFβ signaling.
05/05/2024	PubMed	Identification and characterization of a TLR4 homologue in Eriocheir sinensis based on structure analysis.
07/26/2021	News Article	Acute On Chronic Liver Failure (ACLF) Market Insight, Epidemiology and Market Forecast Report 2021-2030 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions